Trial
NCT02915263
The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
Grifols Biologicals, LLC
Condition
Diabetes Complications
Intervention
IGIV-C
Why stopped
Funding withdrawn in the midst of the COVID pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-07